These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 2540748
1. The benzodiazepine receptor ligands RO 5-4864 and RO 15-1788 do not block the inhibition of PAF-induced platelet aggregation seen with the hetrazepine WEB2086. Griffin K, Hong T, Levy JV. Biochem Biophys Res Commun; 1989 Apr 14; 160(1):263-7. PubMed ID: 2540748 [Abstract] [Full Text] [Related]
2. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors. Takehara S, Mikashima H, Muramoto Y, Terasawa M, Setoguchi M, Tahara T. Prostaglandins; 1990 Dec 14; 40(6):571-83. PubMed ID: 1965554 [Abstract] [Full Text] [Related]
3. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells. Korth R, Hirafuji M, Keraly CL, Delautier D, Bidault J, Benveniste J. Br J Pharmacol; 1989 Oct 14; 98(2):653-61. PubMed ID: 2555017 [Abstract] [Full Text] [Related]
4. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736. Crowley HJ, Yaremko B, Selig WM, Janero DR, Burghardt C, Welton AF, O'Donnell M. J Pharmacol Exp Ther; 1991 Oct 14; 259(1):78-85. PubMed ID: 1656030 [Abstract] [Full Text] [Related]
6. Structure-activity relationships and effects of platelet-activating factor antagonists in the hetrazepine series. Weber KH, Heuer H. Int Arch Allergy Appl Immunol; 1989 Oct 14; 88(1-2):82-7. PubMed ID: 2540098 [Abstract] [Full Text] [Related]
7. The specific binding of the platelet-activating factor (PAF) receptor antagonist WEB 2086 and the benzodiazepine flunitrazepam to rat hepatocytes. Svetlov SI, Barton JM, Olson MS. Life Sci; 1996 Oct 14; 58(5):PL 81-6. PubMed ID: 8594301 [Abstract] [Full Text] [Related]
10. The thieno-triazolodiazepine WEB 2086 inhibits platelet aggregation and ATP release from porcine platelets induced by platelet activating factor (PAF). Griffin KJ, Levy JV. Thromb Res; 1988 Jul 15; 51(2):219-23. PubMed ID: 3187959 [No Abstract] [Full Text] [Related]
11. Characterization of PAF receptors on human neutrophils using the specific antagonist, WEB 2086. Correlation between receptor binding and function. Dent G, Ukena D, Chanez P, Sybrecht G, Barnes P. FEBS Lett; 1989 Feb 27; 244(2):365-8. PubMed ID: 2537761 [Abstract] [Full Text] [Related]
12. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits. Montrucchio G, Alloatti G, Mariano F, Lupia E, Lucchina PG, Musso E, Emanuelli G, Camussi G. Circ Res; 1993 Mar 27; 72(3):658-70. PubMed ID: 8381725 [Abstract] [Full Text] [Related]
13. Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity. Casals-Stenzel J, Weber KH. Br J Pharmacol; 1987 Jan 27; 90(1):139-46. PubMed ID: 2880622 [Abstract] [Full Text] [Related]
14. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages. Stewart AG, Dusting GJ. Br J Pharmacol; 1988 Aug 27; 94(4):1225-33. PubMed ID: 2850058 [Abstract] [Full Text] [Related]
15. Formation of a highly stable complex between BN 50730 [tetrahydro-4,7,8,10 methyl-1(chloro-2 phenyl)-6 (methoxy-4 phenyl-carbamoyl)-9 pyrido [4',3'-4,5] thieno [3,2-f] triazolo-1,2,4 [4,3-a] diazepine-1,4] and the platelet-activating factor receptor in rabbit platelet membranes. Silva CL, Cruz HN, Violante FA, Cordeiro RS, Martins MA, Noël F. Biochem Pharmacol; 1996 Jan 26; 51(2):193-6. PubMed ID: 8615889 [Abstract] [Full Text] [Related]
16. Effects of antiplatelet agents on platelet aggregation induced by platelet--activating factor (PAF) in human whole blood. Chan WP, Levy JV. Prostaglandins; 1991 Oct 26; 42(4):337-42. PubMed ID: 1665568 [Abstract] [Full Text] [Related]
17. Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine. da Silva MB, Herion F, Raskinet R, David JL, Gustin P, Dessy C, Lekeux P. Zentralbl Veterinarmed A; 1996 Sep 26; 43(7):399-413. PubMed ID: 8921726 [Abstract] [Full Text] [Related]
18. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist. Yamada T, Saito M, Mase T, Hara H, Nagaoka H, Murase K, Tomioka K. Lipids; 1991 Dec 26; 26(12):1179-83. PubMed ID: 1668114 [Abstract] [Full Text] [Related]
19. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse. Foster AP, Lees P, Andrews MJ, Cunningham FM. Equine Vet J; 1992 May 26; 24(3):203-7. PubMed ID: 1318830 [Abstract] [Full Text] [Related]
20. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist. Herbert JM, Fraisse L, Bachy A, Valette G, Savi P, Laplace MC, Lassalle J, Roche B, Lale A, Keane PE. J Lipid Mediat; 1993 Aug 26; 8(1):31-51. PubMed ID: 8257776 [Abstract] [Full Text] [Related] Page: [Next] [New Search]